Human urinary kallidinogenase in acute ischemic stroke: A single‐arm, multicenter, phase IV study (RESK study)

Human urinary kallidinogenase (HUK) has shown favorable efficacies in acute ischemic stroke (AIS) treatment. We sought confirmation of the safety and efficacy of HUK for AIS in a large population.

• Publication year

  2021

• Venue

  CNS Neuroscience & Therapeutics

• Publication date

  2021-09-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/cns.13724PMID 34510762PMCID 8611767
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human urinary kallidinogenase in acute ischemic stroke: A single‐arm, multicenter, phase IV study (RESK study)

  2021cited by this paper
• Human urinary kallidinogenase in treating acute ischemic stroke patients: analyses of pooled data from a randomized double-blind placebo-controlled phase IIb and phase III clinical trial

  2020cited by this paper
• Continuous non-invasive optical monitoring of cerebral blood flow and oxidative metabolism after acute brain injury

  2019cited by this paper
• Research on Hospital Medical Crisis Management Based on 4R Theory: A Case Study of the Crisis Event in the Second Affiliated Hospital of Harbin Medical University

  2019cited by this paper
• Effect of Different Classes of Antihypertensive Drugs on Endothelial Function and Inflammation

  2019cited by this paper
• Prevalence, risk factors and secondary prevention of stroke recurrence in eight countries from south, east and southeast asia: a scoping review.

  2018cited by this paper
• Therapeutic Values of Human Urinary Kallidinogenase on Cerebrovascular Diseases

  2018cited by this paper
• The cerebral collateral circulation: Relevance to pathophysiology and treatment of stroke

  2017cited by this paper
• Re-evaluate the Efficacy and Safety of Human Urinary Kallidinogenase (RESK): Protocol for an Open-Label, Single-Arm, Multicenter Phase IV Trial for the Treatment of Acute Ischemic Stroke in Chinese Patients

  2017cited by this paper
• Non-invasive methods for measuring vascular changes in neurovascular headaches

  2017cited by this paper
• Magnitude of Hypotension Based on Office and Ambulatory Blood Pressure Monitoring: Results From a Cohort of 5066 Treated Hypertensive Patients Aged 80 Years and Older.

  2017cited by this paper
• Safety, tolerability and pharmacokinetic profile of recombinant human tissue kallikrein, DM199, after intravenous and subcutaneous administration in healthy volunteers

  2017cited by this paper
• Stroke: a global response is needed

  2016influential reference
• Prediction of Early Recurrence After Acute Ischemic Stroke.

  2016cited by this paper
• Human Urinary Kallidinogenase Improves Outcome of Stroke Patients by Shortening Mean Transit Time of Perfusion Magnetic Resonance Imaging.

  2015cited by this paper
• A randomized trial of intraarterial treatment for acute ischemic stroke.

  2015cited by this paper
• Ischemic Preconditioning: The Long-Awaited Savior of Neuroprotection. Has It Arrived?

  2015cited by this paper
• The Chinese People's Liberation Army

  2015cited by this paper
• Human Urinary Kallidinogenase Promotes Angiogenesis and Cerebral Perfusion in Experimental Stroke

  2015cited by this paper
• Collateral Circulation in Ischemic Stroke: Assessment Tools and Therapeutic Strategies

  2015cited by this paper
• Collateral circulation in acute stroke: assessing methods and impact: a literature review.

  2014cited by this paper
• Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010.

  2014cited by this paper
• HEART DISEASE AND STROKE STATISTICS–2014 UPDATE: A REPORT FROM THE AMERICAN HEART ASSOCIATION

  2014cited by this paper
• Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

  2014cited by this paper
• Prospective, Multicenter, Single-Arm Study of Mechanical Thrombectomy Using Solitaire Flow Restoration in Acute Ischemic Stroke

  2013cited by this paper
• Chinese herbal formulas for treating hypertension in traditional Chinese medicine: perspective of modern science

  2013cited by this paper
• Endovascular treatment for acute ischemic stroke.

  2013cited by this paper
• Efficacy and safety of human urinary kallidinogenase injection for acute ischemic stroke: A systematic review

  2012cited by this paper
• Futile recanalization in mechanical embolectomy trials: a call to improve selection of patients for revascularization.

  2010cited by this paper
• Outcomes of Thrombolytic Therapy for Acute Ischemic Stroke in Chinese Patients

  2010cited by this paper
• Outcomes of Thrombolytic Therapy for Acute Ischemic Stroke in Chinese Patients: The Taiwan Thrombolytic Therapy for Acute Ischemic Stroke (TTT-AIS) Study

  2010cited by this paper
• Treatment of acute ischemic stroke in China

  2009cited by this paper
• A multicenter,randomized,double-blinded and placebo-controlled study of acute brain infarction treated by human urinary kallidinogenase

  2007cited by this paper
• Alteplase at 0.6 mg/kg for Acute Ischemic Stroke Within 3 Hours of Onset: Japan Alteplase Clinical Trial (J-ACT)

  2006cited by this paper
• Risk factors for early recurrence after ischemic stroke: the role of stroke syndrome and subtype.

  1998cited by this paper

• Functional Outcomes of Human Urinary Kallindinogenases in Treatment of Acute Ischemic Stroke.

  2025cites this paper
• Adjunctive Human Urinary Kallidinogenase Enhances the Cognitive and Hemodynamic Outcomes of Anterior Circulation Stenting

  2025cites this paper
• Efficacy of Human Urinary Kallidinogenase in Real-world Patients With Acute Ischemic Stroke

  2025cites this paper
• Role of human urinary kallikrein in reducing progressive ischemic stroke among acute ischemic stroke patients with concurrent hypertension and diabetes: a hospital-based retrospective cohort study

  2025cites this paper
• Recombinant Human Tissue Kallikrein-1 for Treating Acute Ischemic Stroke and Preventing Recurrence

  2025cites this paper
• Unlocking the therapeutic potential of human urinary kallidinogenase in stroke: a mini review

  2025cites this paper
• Cost-effectiveness of edaravone dexborneol sublingual tablet versus concentrated solution for injection for the treatment of acute ischemic stroke in China

  2025cites this paper
• Editorial: Advances in diabetes and hypertension research

  2025cites this paper
• The Role of the Complement System in Synaptic Pruning after Stroke

  2024cites this paper
• Cost-effectiveness of edaravone dexborneol versus human urinary kallidinogenase for acute ischemic stroke in China

  2024cites this paper
• The effectiveness and safety of human urinary kallidinogenase in acute ischemic stroke patients undergoing endovascular therapy

  2024cites this paper
• Recent advances in the discovery and development of drugs targeting the kallikrein-kinin system

  2024cites this paper
• Multimodal imaging evaluation of early neurological deterioration following acute ischemic stroke

  2024cites this paper
• Advancements in Ischemic Stroke Management: Transition from Traditional to Nanotechnological Approaches

  2024cites this paper
• A comprehensive review of stroke-related signaling pathways and treatment in western medicine and traditional Chinese medicine

  2023cites this paper
• Efficacy of Urinary Kallidinogenase Plus Intravenous Recombinant Tissue Plasminogen Activator for Stroke Patients With Extended Window

  2023cites this paper
• Clinical efficacy analysis of butylphthalide combined with urinary kallidinogenase in treating chronic cerebral circulatory insufficiency

  2023cites this paper
• Evolution of ischemic stroke drug clinical trials in mainland China from 2005 to 2021

  2022cites this paper
• Human urinary kallidinogenase decreases the incidence of post-stroke cognitive impairment in acute ischemic stroke patients.

  2022cites this paper
• Human urinary kallidinogenase in acute ischemic stroke: A single‐arm, multicenter, phase IV study (RESK study)

  2021cites this paper